Correlation Between Unicycive Therapeutics and Fast Retailing

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Fast Retailing at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Fast Retailing into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and Fast Retailing Co, you can compare the effects of market volatilities on Unicycive Therapeutics and Fast Retailing and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Fast Retailing. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Fast Retailing.

Diversification Opportunities for Unicycive Therapeutics and Fast Retailing

-0.45

Correlation Coefficient

Unicycive Therapeutics  Fast Retailing

Very good diversification

The 3 months correlation between Unicycive and Fast is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Fast Retailing Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fast Retailing and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Fast Retailing. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fast Retailing has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Fast Retailing go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Fast Retailing

Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.41 times less return on investment than Fast Retailing. But when comparing it to its historical volatility, Unicycive Therapeutics is 1.16 times less risky than Fast Retailing. It trades about 0.04 of its potential returns per unit of risk. Fast Retailing Co is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  19,143  in Fast Retailing Co on October 12, 2024 and sell it today you would earn a total of  12,512  from holding Fast Retailing Co or generate 65.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	75.96%
Values	Daily Returns

Unicycive Therapeutics  vs.  Fast Retailing Co

Unicycive Therapeutics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Fast Retailing

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fast Retailing Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Unicycive Therapeutics and Fast Retailing

The main advantage of trading using opposite Unicycive Therapeutics and Fast Retailing positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Fast Retailing can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fast Retailing will offset losses from the drop in Fast Retailing's long position.

The idea behind Unicycive Therapeutics and Fast Retailing Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.